The diagnosis of hemolytic anemia was established mainly by the clinical observation of either a fall in circulating hemoglobin levels or a loss of transfused blood in excess of 1 per cent per day.

Johnson & Johnson JNJ announced that the FDA has accepted its regulatory filing seeking the FDA’s approval for nipocalimab, ...

Initiate pivotal studies for NX-5948: Nurix is evaluating NX-5948 in an ongoing Phase 1b clinical trial in adults with relapsed or refractory B-cell malignancies and expects to initiate a suite of ...

Expresses differences in erythrocyte size in an individual specimen Used to detect anisocytosis. Increased in immune hemolytic anemia, SS and SC disease, and hereditary spherocytosis ...

Agios Pharmaceuticals, Inc. (AGIO), on Wednesday, announced that its supplemental New Drug Application seeking approval for the ...

Pediatric patients with sickle cell anemia and a history of abnormal cerebral artery velocities had reduced hospitalizations ...

Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.

Physicians or patients who wish to participate in the 60 Degrees Pharmaceuticals Tafenoquine for Babesiosis Expanded Access clinical study are encouraged to visit the Company’s website for information ...

Expresses differences in erythrocyte size in an individual specimen Used to detect anisocytosis. Increased in immune hemolytic anemia, SS and SC disease, and hereditary spherocytosis ...